KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment-Reference-Cited by-同舟云学术

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

Published:2018-10-10 Issue:10 Volume:13 Page:e0205430
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ruiz-Iruela Cristina^ORCID,Padró-Miquel Ariadna,Pintó-Sala Xavier,Baena-Díez Neus,Caixàs-Pedragós Assumpta,Güell-Miró Roser,Navarro-Badal Rosa^ORCID,Jusmet-Miguel Xavier,Calmarza Pilar,Puzo-Foncilla José Luis,Alía-Ramos Pedro,Candás-Estébanez Beatriz

Funder

Barcelona’s Professional Pharmacist Association

Fundación José Luis Castaño (FENIN scholarship 2014)

Fundació Parc Taulí Institut Universitari UAB (Parc Taulí Recerca scholarship 2012)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Genetic determinants of statin-induced low-density lipoprotein colesterol reduction: The Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial;DI Chasman;Circ Cardiovasc Genet,2012

2. Ministerio de Sanidad, Servicios Sociales e Igualdad: National Healthcare system Anual Report, 2016. Available in www.msssi.gob.es.

3. Comparative effects of lipid-lowering therapies;MH Davidson;Progress in Cardiovascular Diseases,2004

4. Pharmacogenomics of statins: understanding susceptibility to adverse effects;JP Kitzmiller;Pharmacogenomics and Personalized Medicine,2016

5. Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia;WD Maxwell;Pharmacotherapy,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Determinants of Response to Statins in Cardiovascular Diseases;Current Cardiology Reviews;2024-03

2. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability;Pharmacogenetics and Genomics;2024-02-07

3. Impact of KIF6 Trp719Arg gene variant on Coronary Artery Disease Development;2023-03-21

4. Pharmacogenomics in Cardiovascular Diseases;Pharmacogenomics in Clinical Practice;2023

5. Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients;PLOS ONE;2022-07-15